406 related articles for article (PubMed ID: 30194658)
41. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
[TBL] [Abstract][Full Text] [Related]
42. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
43. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.
Trentham-Dietz A; Ergun MA; Alagoz O; Stout NK; Gangnon RE; Hampton JM; Dittus K; James TA; Vacek PM; Herschorn SD; Burnside ES; Tosteson ANA; Weaver DL; Sprague BL
Breast Cancer Res Treat; 2018 Feb; 168(1):229-239. PubMed ID: 29185118
[TBL] [Abstract][Full Text] [Related]
44. MR imaging of ductal carcinoma in situ.
Newstead GM
Magn Reson Imaging Clin N Am; 2010 May; 18(2):225-40, viii. PubMed ID: 20494308
[TBL] [Abstract][Full Text] [Related]
45. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
46. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
47. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
48. Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast.
Amari M; Moriya T; Ishida T; Harada Y; Ohnuki K; Takeda M; Sasano H; Horii A; Ohuchi N
Jpn J Clin Oncol; 2003 Nov; 33(11):556-62. PubMed ID: 14711979
[TBL] [Abstract][Full Text] [Related]
49. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
[TBL] [Abstract][Full Text] [Related]
50. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy.
Wang HH; Ducatman BS; Eick D
Am J Clin Pathol; 1989 Dec; 92(6):736-40. PubMed ID: 2556017
[TBL] [Abstract][Full Text] [Related]
51. [Ductal carcinoma in situ].
Skaar M; Langhans L; Mertz B; Kroman N
Ugeskr Laeger; 2018 Sep; 180(38):. PubMed ID: 30259839
[TBL] [Abstract][Full Text] [Related]
52. Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.
Sherman ME; Mies C; Gierach GL
Breast Dis; 2014; 34(3):105-16. PubMed ID: 24225267
[TBL] [Abstract][Full Text] [Related]
53. Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.
Delaloge S; Khan SA; Wesseling J; Whelan T
Lancet; 2024 Jun; 403(10445):2734-2746. PubMed ID: 38735296
[TBL] [Abstract][Full Text] [Related]
54. Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosis.
Wärnberg F; Casalini P; Nordgren H; Bergkvist L; Holmberg L; Ménard S
Breast Cancer Res Treat; 2002 Jun; 73(3):215-21. PubMed ID: 12160327
[TBL] [Abstract][Full Text] [Related]
55. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
56. The diagnosis and management of ductal carcinoma in-situ of the breast.
Winchester DP; Jeske JM; Goldschmidt RA
CA Cancer J Clin; 2000; 50(3):184-200. PubMed ID: 10901741
[TBL] [Abstract][Full Text] [Related]
57. Detection Rates of Ductal Carcinoma in Situ with Biennial Digital Mammography Screening: Radiologic Findings Support Pathologic Model of Tumor Progression.
Weigel S; Khil L; Hense HW; Decker T; Wellmann J; Heidrich J; Sommer A; Heidinger O; Heindel W
Radiology; 2018 Feb; 286(2):424-432. PubMed ID: 29106821
[TBL] [Abstract][Full Text] [Related]
58. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
59. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
60. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
